Registro:

Referencias:

• Friedlander, M., Dorrell, M.I., Ritter, M.R., Marchetti, V., Moreno, S.K., El-Kalay, M., Bird, A.C., Aguilar, E., Progenitor cells and retinal angiogenesis (2007) Angiogenesis, 10, pp. 89-101
• Diabetic Retinopathy Clinical Research, N., Wells, J.A., Glassman, A.R., Ayala, A.R., Jampol, L.M., Aiello, L.P., Antoszyk, A.N., Ferris, F.L., Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema (2015) N Engl J Med, 372, pp. 1193-1203
• Durham, J.T., Herman, I.M., Microvascular modifications in diabetic retinopathy (2011) Curr Diab Rep, 11, pp. 253-264
• Aiello, L.P., Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies (1997) Ophthalmic Res, 29, pp. 354-362
• Das, A., McGuire, P.G., Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition (2003) Prog Retin Eye Res, 22, pp. 721-748
• Chung, A.S., Ferrara, N., Developmental and pathological angiogenesis (2011) Annu Rev Cell Dev Biol, 27, pp. 563-584
• Tah, V., Orlans, H.O., Hyer, J., Casswell, E., Din, N., Sri Shanmuganathan, V., Ramskold, L., Pasu, S., Anti-VEGF Therapy and the Retina: An Update (2015) J Ophthalmol, 2015
• Dorrell, M.I., Aguilar, E., Jacobson, R., Trauger, S.A., Friedlander, J., Siuzdak, G., Friedlander, M., Maintaining retinal astrocytes normalizes revascularization and prevents vascular pathology associated with oxygen-induced retinopathy (2010) Glia, 58, pp. 43-54
• Fu, Z., Nian, S., Li, S.Y., Wong, D., Chung, S.K., Lo, A.C., Deficiency of aldose reductase attenuates inner retinal neuronal changes in a mouse model of retinopathy of prematurity (2015) Graefes Arch Clin Exp Ophthalmol, 253, pp. 1503-1513
• Liu, X., Wang, D., Liu, Y., Luo, Y., Ma, W., Xiao, W., Yu, Q., Neuronal-driven angiogenesis: role of NGF in retinal neovascularization in an oxygen-induced retinopathy model (2010) Invest Ophthalmol Vis Sci, 51, pp. 3749-3757
• Bringmann, A., Pannicke, T., Grosche, J., Francke, M., Wiedemann, P., Skatchkov, S.N., Osborne, N.N., Reichenbach, A., Muller cells in the healthy and diseased retina (2006) Prog Retin Eye Res, 25, pp. 397-424
• Barcelona, P.F., Ortiz, S.G., Chiabrando, G.A., Sanchez, M.C., alpha2-Macroglobulin induces glial fibrillary acidic protein expression mediated by low-density lipoprotein receptorrelated protein 1 in Muller cells (2011) Invest Ophthalmol Vis Sci, 52, pp. 778-786
• Barcelona, P.F., Jaldin-Fincati, J.R., Sanchez, M.C., Chiabrando, G.A., Activated alpha2-macroglobulin induces Muller glial cell migration by regulating MT1-MMP activity through LRP1 (2013) FASEB J, 27, pp. 3181-3197
• Lorenc, V.E., Jaldin-Fincati, J.R., Luna, J.D., Chiabrando, G.A., Sanchez, M.C., IGF-1 Regulates the Extracellular Level of Active MMP-2 and Promotes Muller Glial Cell Motility (2015) Invest Ophthalmol Vis Sci, 56, pp. 6948-6960
• Cristina Hernández, M.D.M., Simó, R., Casini, G., Neuroprotection as a Therapeutic Target for Diabetic Retinopathy (2016) Journal of Diabetes Research, 2016, p. 18
• Kim, C.B., D'Amore, P.A., Connor, K.M., Revisiting the mouse model of oxygen-induced retinopathy (2016) Eye Brain, 8, pp. 67-79
• Croci, D.O., Salatino, M., Rubinstein, N., Cerliani, J.P., Cavallin, L.E., Leung, H.J., Ouyang, J., Mesri, E.A., Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma (2012) J Exp Med, 209, pp. 1985-2000
• Baston, J.I., Baranao, R.I., Ricci, A.G., Bilotas, M.A., Olivares, C.N., Singla, J.J., Gonzalez, A.M., Meresman, G.F., Targeting galectin-1-induced angiogenesis mitigates the severity of endometriosis (2014) J Pathol, 234, pp. 329-337
• Kanda, A., Noda, K., Saito, W., Ishida, S., Aflibercept Traps Galectin-1, an Angiogenic Factor Associated with Diabetic Retinopathy (2015) Sci Rep, 5, p. 17946
• Thijssen, V.L., Postel, R., Brandwijk, R.J., Dings, R.P., Nesmelova, I., Satijn, S., Verhofstad, N., Griffioen, A.W., Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy (2006) Proc Natl Acad Sci U S A, 103, pp. 15975-15980
• Laderach, D.J., Gentilini, L.D., Giribaldi, L., Delgado, V.C., Nugnes, L., Croci, D.O., Al Nakouzi, N., Chauchereau, A., A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease (2013) Cancer Res, 73, pp. 86-96
• Starossom, S.C., Mascanfroni, I.D., Imitola, J., Cao, L., Raddassi, K., Hernandez, S.F., Bassil, R., Khoury, S.J., Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration (2012) Immunity, 37, pp. 249-263
• Rabinovich, G.A., Croci, D.O., Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer (2012) Immunity, 36, pp. 322-335
• Rubinstein, N., Alvarez, M., Zwirner, N.W., Toscano, M.A., Ilarregui, J.M., Bravo, A., Mordoh, J., Rabinovich, G.A., Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumorimmune privilege (2004) Cancer Cell, 5, pp. 241-251
• Banh, A., Zhang, J., Cao, H., Bouley, D.M., Kwok, S., Kong, C., Giaccia, A.J., Le, Q.T., Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis (2011) Cancer Res, 71, pp. 4423-4431
• Dalotto-Moreno, T., Croci, D.O., Cerliani, J.P., Martinez-Allo, V.C., Dergan-Dylon, S., Mendez-Huergo, S.P., Stupirski, J.C., Salatino, M., Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease (2013) Cancer Res, 73, pp. 1107-1117
• Le, Q.T., Shi, G., Cao, H., Nelson, D.W., Wang, Y., Chen, E.Y., Zhao, S., Koong, A.C., Galectin-1: a link between tumor hypoxia and tumor immune privilege (2005) J Clin Oncol, 23, pp. 8932-8941
• Hsieh, S.H., Ying, N.W., Wu, M.H., Chiang, W.F., Hsu, C.L., Wong, T.Y., Jin, Y.T., Chen, Y.L., Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells (2008) Oncogene, 27, pp. 3746-3753
• D'Haene, N., Sauvage, S., Maris, C., Adanja, I., Le Mercier, M., Decaestecker, C., Baum, L., Salmon, I., VEGFR1 and VEGFR2 involvement in extracellular galectin-1-and galectin-3-induced angiogenesis (2013) PLoS One, 8
• Croci, D.O., Cerliani, J.P., Dalotto-Moreno, T., Mendez-Huergo, S.P., Mascanfroni, I.D., Dergan-Dylon, S., Toscano, M.A., Bais, C., Glycosylation-dependent lectinreceptor interactions preserve angiogenesis in anti-VEGF refractory tumors (2014) Cell, 156, pp. 744-758
• Smith, L.E., Wesolowski, E., McLellan, A., Kostyk, S.K., D'Amato, R., Sullivan, R., D'Amore, P.A., Oxygen-induced retinopathy in the mouse (1994) Invest Ophthalmol Vis Sci, 35, pp. 101-111
• Connor, K.M., Krah, N.M., Dennison, R.J., Aderman, C.M., Chen, J., Guerin, K.I., Sapieha, P., Smith, L.E., Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis (2009) Nat Protoc, 4, pp. 1565-1573
• Liu, G.D., Xu, C., Feng, L., Wang, F., The augmentation of O-GlcNAcylation reduces glyoxal-induced cell injury by attenuating oxidative stress in human retinal microvascular endothelial cells (2015) Int J Mol Med, 36, pp. 1019-1027
• Simo, R., Carrasco, E., Garcia-Ramirez, M., Hernandez, C., Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy (2006) Curr Diabetes Rev, 2, pp. 71-98
• Campochiaro, P.A., Molecular pathogenesis of retinal and choroidal vascular diseases (2015) Prog Retin Eye Res, 49, pp. 67-81
• Liang, X., Zhou, H., Ding, Y., Li, J., Yang, C., Luo, Y., Li, S., Min, W., TMP prevents retinal neovascularization and imparts neuroprotection in an oxygen-induced retinopathy model (2012) Invest Ophthalmol Vis Sci, 53, pp. 2157-2169
• Vessey, K.A., Wilkinson-Berka, J.L., Fletcher, E.L., Characterization of retinal function and glial cell response in a mouse model of oxygen-induced retinopathy (2011) J Comp Neurol, 519, pp. 506-527
• Fletcher, E.L., Downie, L.E., Hatzopoulos, K., Vessey, K.A., Ward, M.M., Chow, C.L., Pianta, M.J., Wilkinson-Berka, J.L., The significance of neuronal and glial cell changes in the rat retina during oxygen-induced retinopathy (2010) Doc Ophthalmol, 120, pp. 67-86
• Sanchez, M.C., Barcelona, P.F., Luna, J.D., Ortiz, S.G., Juarez, P.C., Riera, C.M., Chiabrando, G.A., Low-density lipoprotein receptor-related protein-1 (LRP-1) expression in a rat model of oxygen-induced retinal neovascularization (2006) Exp Eye Res, 83, pp. 1378-1385
• Bringmann, A., Iandiev, I., Pannicke, T., Wurm, A., Hollborn, M., Wiedemann, P., Osborne, N.N., Reichenbach, A., Cellular signaling and factors involved in Muller cell gliosis: neuroprotective and detrimental effects (2009) Prog Retin Eye Res, 28, pp. 423-451
• Duan, L.J., Takeda, K., Fong, G.H., Prolyl hydroxylase domain protein 2 (PHD2) mediates oxygen-induced retinopathy in neonatal mice (2011) Am J Pathol, 178, pp. 1881-1890
• Narayanan, S.P., Xu, Z., Putluri, N., Sreekumar, A., Lemtalsi, T., Caldwell, R.W., Caldwell, R.B., Arginase 2 deficiency reduces hyperoxia-mediated retinal neurodegeneration through the regulation of polyamine metabolism (2014) Cell Death Dis, 5
• Wang, L., Shi, P., Xu, Z., Li, J., Xie, Y., Mitton, K., Drenser, K., Yan, Q., Up-regulation of VEGF by retinoic acid during hyperoxia prevents retinal neovascularization and retinopathy (2014) Invest Ophthalmol Vis Sci, 55, pp. 4276-4287
• Lewis, G.P., Matsumoto, B., Fisher, S.K., Changes in the organization and expression of cytoskeletal proteins during retinal degeneration induced by retinal detachment (1995) Invest Ophthalmol Vis Sci, 36, pp. 2404-2416
• Sethi, C.S., Lewis, G.P., Fisher, S.K., Leitner, W.P., Mann, D.L., Luthert, P.J., Charteris, D.G., Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy (2005) Invest Ophthalmol Vis Sci, 46, pp. 329-342
• Bringmann, A., Pannicke, T., Biedermann, B., Francke, M., Iandiev, I., Grosche, J., Wiedemann, P., Reichenbach, A., Role of retinal glial cells in neurotransmitter uptake and metabolism (2009) Neurochem Int, 54, pp. 143-160
• Harada, T., Harada, C., Nakamura, K., Quah, H.M., Okumura, A., Namekata, K., Saeki, T., Tanaka, K., The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma (2007) J Clin Invest, 117, pp. 1763-1770
• Croci, D.O., Cerliani, J.P., Pinto, N.A., Morosi, L.G., Rabinovich, G.A., Regulatory role of glycans in the control of hypoxiadriven angiogenesis and sensitivity to anti-angiogenic treatment (2014) Glycobiology, 24, pp. 1283-1290
• Manzi, M., Bacigalupo, M.L., Carabias, P., Elola, M.T., Wolfenstein-Todel, C., Rabinovich, G.A., Espelt, M.V., Troncoso, M.F., Galectin-1 Controls the Proliferation and Migration of Liver Sinusoidal Endothelial Cells and Their Interaction With Hepatocarcinoma Cells (2016) J Cell Physiol, 231, pp. 1522-1533
• Van Mourik, T.R., Lappchen, T., Rossin, R., Van Beijnum, J.R., Macdonald, J.R., Mayo, K.H., Griffioen, A.W., Grull, H., Evaluation of 111In-labeled Anginex as Potential SPECT Tracer for Imaging of Tumor Angiogenesis (2015) Anticancer Res, 35, pp. 5945-5954
• Salatino, M., Croci, D.O., Laderach, D.J., Compagno, D., Gentilini, L., Dalotto-Moreno, T., Dergan-Dylon, L.S., Rabinovich, G.A., Regulation of galectins by hypoxia and their relevance in angiogenesis: strategies and methods (2015) Methods Mol Biol, 1207, pp. 293-304
• Endo, T., Glycans and glycan-binding proteins in brain: galectin-1-induced expression of neurotrophic factors in astrocytes (2005) Curr Drug Targets, 6, pp. 427-436
• Maldonado, C.A., Castagna, L.F., Rabinovich, G.A., Landa, C.A., Immunocytochemical study of the distribution of a 16-kDa galectin in the chicken retina (1999) Invest Ophthalmol Vis Sci, 40, pp. 2971-2977
• Chen, W.S., Cao, Z., Leffler, H., Nilsson, U.J., Panjwani, N., Galectin-3 Inhibition by a Small-Molecule Inhibitor Reduces Both Pathological Corneal Neovascularization and Fibrosis (2017) Invest Ophthalmol Vis Sci, 58, pp. 9-20
• Sapieha, P., Joyal, J.S., Rivera, J.C., Kermorvant-Duchemin, E., Sennlaub, F., Hardy, P., Lachapelle, P., Chemtob, S., Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life (2010) J Clin Invest, 120, pp. 3022-3032
• Niesman, M.R., Johnson, K.A., Penn, J.S., Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity (1997) Neurochem Res, 22, pp. 597-605
• Penn, J.S., Tolman, B.L., Bullard, L.E., Effect of a water-soluble vitamin E analog, trolox C, on retinal vascular development in an animal model of retinopathy of prematurity (1997) Free Radic Biol Med, 22, pp. 977-984
• Inafuku, S., Noda, K., Amano, M., Ohashi, T., Yoshizawa, C., Saito, W., Murata, M., Ishida, S., Alteration of N-Glycan Profiles in Diabetic Retinopathy (2015) Invest Ophthalmol Vis Sci, 56, pp. 5316-5322
• Sirko, S., Irmler, M., Gascon, S., Bek, S., Schneider, S., Dimou, L., Obermann, J., Gotz, M., Astrocyte reactivity after brain injury-: The role of galectins 1 and 3 (2015) Glia, 63, pp. 2340-2361
• Gaudet, A.D., Sweet, D.R., Polinski, N.K., Guan, Z., Popovich, P.G., Galectin-1 in injured rat spinal cord: implications for macrophage phagocytosis and neural repair (2015) Mol Cell Neurosci, 64, pp. 84-94
• Quinta, H.R., Pasquini, J.M., Rabinovich, G.A., Pasquini, L.A., Glycan-dependent binding of galectin-1 to neuropilin-1 promotes axonal regeneration after spinal cord injury (2014) Cell Death Differ, 21, pp. 941-955
• Kobayakawa, Y., Sakumi, K., Kajitani, K., Kadoya, T., Horie, H., Kira, J., Nakabeppu, Y., Galectin-1 deficiency improves axonal swelling of motor neurones in SOD1(G93A) transgenic mice (2015) Neuropathol Appl Neurobiol, 41, pp. 227-244
• Eastlake, K., Heywood, W.E., Tracey-White, D., Aquino, E., Bliss, E., Vasta, G.R., Mills, K., Limb, G.A., Comparison of proteomic profiles in the zebrafish retina during experimental degeneration and regeneration (2017) Sci Rep, 7, p. 44601
• Osaadon, P., Fagan, X.J., Lifshitz, T., Levy, J., A review of anti-VEGF agents for proliferative diabetic retinopathy (2014) Eye (Lond), 28, pp. 510-520
• Akkoyun, I., Karabay, G., Haberal, N., Dagdeviren, A., Yilmaz, G., Oto, S., Erkanli, L., Akova, Y.A., Structural consequences after intravitreal bevacizumab injection without increasing apoptotic cell death in a retinopathy of prematurity mouse model (2012) Acta Ophthalmol, 90, pp. 564-570
• Feng, F., Cheng, Y., Liu, Q.H., Bevacizumab treatment reduces retinal neovascularization in a mouse model of retinopathy of prematurity (2014) Int J Ophthalmol, 7, pp. 608-613
• Ridano, M.E., Racca, A.C., Flores-Martin, J., Camolotto, S.A., de Potas, G.M., Genti-Raimondi, S., Panzetta-Dutari, G.M., Chlorpyrifos modifies the expression of genes involved in human placental function (2012) Reprod Toxicol, 33, pp. 331-338
• Kahn, R., Buse, J., Ferrannini, E., Stern, M., The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes (2005) Diabetologia, 48, pp. 1684-1699
• Sanchez, M.C., Luna, J.D., Barcelona, P.F., Gramajo, A.L., Juarez, P.C., Riera, C.M., Chiabrando, G.A., Effect of retinal laser photocoagulation on the activity of metalloproteinases and the alpha(2)-macroglobulin proteolytic state in the vitreous of eyes with proliferative diabetic retinopathy (2007) Exp Eye Res, 85, pp. 644-650

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------